An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris

Status:
Withdrawn

Trial end date:
2013-10-01

Target enrollment:

Participant gender:

This study will assess the safety, tolerability, and efficacy of dapsone in subjects with acne vulgaris following 12 weeks of treatment.

Phase 1

Allergan

Dapsone